Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7944 results

Sort By:

Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma

Study ID: NCT05526989
Start Date: 2022-12-28
End Date: 2027-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

25

Intervention / Treatment

Supplied

Nirparb

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Source: clinicaltrials.gov

Share:
Add to list

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

Study ID: NCT06475989
Start Date: 2024-08-22
End Date: 2030-09-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

264

Intervention / Treatment

Biospecimen Collection

Cabozantinib

Computed Tomography

Dabrafenib

Magnetic Resonance Imaging

Administration questionnaire

Trametinib

Sponsor

ECOG-ACRIN Cancer Research Group

Source: clinicaltrials.gov

Share:
Add to list

Study of AZD0754 in Participants With Metastatic Prostate Cancer

Study ID: NCT06267729
Start Date: 2024-03-12
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

0754

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

Yoga Intervention for the Improvement of Cancer-Related Stress in Cancer Survivors

Study ID: NCT04754529
Start Date: 2021-11-11
End Date: 2025-05-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Quality-of-Life Assessment

Survey Administration

Yoga

Sponsor

Roswell Park Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Long Term Follow-up of Mesothelioma Patients and Their Family Members With Germline Mutations in BAP1 and Other Genes

Study ID: NCT03830229
Start Date: 2019-03-13
End Date: 2027-07-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment
Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells

Study ID: NCT03692429
Start Date: 2018-11-28
End Date: 2036-02-17
Study Type

Interventional

Study Phase

Phase1

No. of Participants

49

Intervention / Treatment

Syed-101

FOLFOX

FOLFIRI

Sponsor

Celyad oncology to

Source: clinicaltrials.gov

Share:
Add to list

Phase 2 Safety and Efficacy Evaluation of AL8326 in ≥2nd Line SCLC

Study ID: NCT05363280
Start Date: 2022-11-01
End Date: 2025-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

36

Intervention / Treatment

AL8326 low dose group

AL8326 middle dose group

AL8326 high dose group

Sponsor

Advenchen Pharmaceuticals, LLC.

Source: clinicaltrials.gov

Share:
Add to list

Proton Radiation Therapy Registry

Study ID: NCT04376229
Start Date: 2020-04-07
End Date: 2040-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

5000

Intervention / Treatment

Registry

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer

Study ID: NCT06574880
Start Date: 2025-05-01
End Date: 2026-09-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

45

Intervention / Treatment

LU-PSMA-617

5-fraction Stereotactic Body Radiation Therapy (SBRT)

Sponsor

Angela Y. Jia, MD PhD

Source: clinicaltrials.gov

Share:
Add to list

A First-In Human (FIH) Trial to Find Out if REGN10597 is Safe and How Well it Works for Adult Participants With Advanced Solid Organ Malignancies

Study ID: NCT06413680
Start Date: 2024-09-23
End Date: 2030-02-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

150

Intervention / Treatment

REGN10597

Sponsor

Regeneron Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list